195 related articles for article (PubMed ID: 22474738)
1. Tezosentan inhibits uptake of proinflammatory endothelin-1 in stenotic aortic valves.
Leskelä HV; Vuolteenaho O; Koivula MK; Taskinen P; Ruskoaho H; Peltonen T; Lehenkari P
J Heart Valve Dis; 2012 Jan; 21(1):23-30. PubMed ID: 22474738
[TBL] [Abstract][Full Text] [Related]
2. The dual endothelin receptor antagonist tezosentan acutely improves hemodynamic parameters in patients with advanced heart failure.
Schalcher C; Cotter G; Reisin L; Bertel O; Kobrin I; Guyene TT; Kiowski W
Am Heart J; 2001 Aug; 142(2):340-9. PubMed ID: 11479476
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
[TBL] [Abstract][Full Text] [Related]
4. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: role of Smad1 and extracellular signal-regulated kinase 1/2.
Yang X; Meng X; Su X; Mauchley DC; Ao L; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2009 Oct; 138(4):1008-15. PubMed ID: 19664780
[TBL] [Abstract][Full Text] [Related]
6. Statin treatment and gene expression of anti-atherogenic factor C-type natriuretic peptide system in stenotic aortic valves.
Peltonen T; Ohtonen P; Näpänkangas J; Ohukainen P; Ruskoaho H; Taskinen P
J Heart Valve Dis; 2011 Sep; 20(5):545-51. PubMed ID: 22066359
[TBL] [Abstract][Full Text] [Related]
7. Increase in tissue endothelin-1 and ETA receptor levels in human aortic valve stenosis.
Peltonen T; Taskinen P; Näpänkangas J; Leskinen H; Ohtonen P; Soini Y; Juvonen T; Satta J; Vuolteenaho O; Ruskoaho H
Eur Heart J; 2009 Jan; 30(2):242-9. PubMed ID: 19008257
[TBL] [Abstract][Full Text] [Related]
8. VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: effects of statins.
Anger T; Pohle FK; Kandler L; Barthel T; Ensminger SM; Fischlein T; Weyand M; Stumpf C; Daniel WG; Garlichs CD
Exp Mol Pathol; 2007 Dec; 83(3):435-42. PubMed ID: 17490641
[TBL] [Abstract][Full Text] [Related]
9. Bone regulatory factors NFATc1 and Osterix in human calcific aortic valves.
Alexopoulos A; Bravou V; Peroukides S; Kaklamanis L; Varakis J; Alexopoulos D; Papadaki H
Int J Cardiol; 2010 Mar; 139(2):142-9. PubMed ID: 19019468
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-α accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway.
Yu Z; Seya K; Daitoku K; Motomura S; Fukuda I; Furukawa K
J Pharmacol Exp Ther; 2011 Apr; 337(1):16-23. PubMed ID: 21205918
[TBL] [Abstract][Full Text] [Related]
11. Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis.
Peltonen TO; Taskinen P; Soini Y; Rysä J; Ronkainen J; Ohtonen P; Satta J; Juvonen T; Ruskoaho H; Leskinen H
Circulation; 2007 Sep; 116(11):1283-9. PubMed ID: 17709640
[TBL] [Abstract][Full Text] [Related]
12. Stenotic aortic valves have dysfunctional mechanisms of anti-inflammation: implications for aortic stenosis.
Lee JH; Meng X; Weyant MJ; Reece TB; Cleveland JC; Fullerton DA
J Thorac Cardiovasc Surg; 2011 Feb; 141(2):481-6. PubMed ID: 21241861
[TBL] [Abstract][Full Text] [Related]
13. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2.
Yang X; Fullerton DA; Su X; Ao L; Cleveland JC; Meng X
J Am Coll Cardiol; 2009 Feb; 53(6):491-500. PubMed ID: 19195606
[TBL] [Abstract][Full Text] [Related]
14. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
[TBL] [Abstract][Full Text] [Related]
15. New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.
Perrotta I; Russo E; Camastra C; Filice G; Di Mizio G; Colosimo F; Ricci P; Tripepi S; Amorosi A; Triumbari F; Donato G
Histopathology; 2011 Sep; 59(3):504-13. PubMed ID: 22034890
[TBL] [Abstract][Full Text] [Related]
16. Systemic and local levels of fetuin-A in calcific aortic valve stenosis.
Kaden JJ; Reinöhl JO; Blesch B; Brueckmann M; Haghi D; Borggrefe M; Schmitz F; Klomfass S; Pillich M; Ortlepp JR
Int J Mol Med; 2007 Aug; 20(2):193-7. PubMed ID: 17611637
[TBL] [Abstract][Full Text] [Related]
17. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis.
Kaden JJ; Bickelhaupt S; Grobholz R; Vahl CF; Hagl S; Brueckmann M; Haase KK; Dempfle CE; Borggrefe M
J Heart Valve Dis; 2004 Jul; 13(4):560-6. PubMed ID: 15311861
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers are associated with a lower remodelling score of stenotic aortic valves.
Côté N; Couture C; Pibarot P; Després JP; Mathieu P
Eur J Clin Invest; 2011 Nov; 41(11):1172-9. PubMed ID: 21988540
[TBL] [Abstract][Full Text] [Related]
19. Apelin and its receptor APJ in human aortic valve stenosis.
Peltonen T; Näpänkangas J; Vuolteenaho O; Ohtonen P; Soini Y; Juvonen T; Satta J; Ruskoaho H; Taskinen P
J Heart Valve Dis; 2009 Nov; 18(6):644-52. PubMed ID: 20099713
[TBL] [Abstract][Full Text] [Related]
20. Transcription factor Egr-1 in calcific aortic valve disease.
Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
